These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17309322)

  • 1. Therapeutic potential of TGF-beta inhibition in chronic renal failure.
    Gagliardini E; Benigni A
    Expert Opin Biol Ther; 2007 Mar; 7(3):293-304. PubMed ID: 17309322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of anti-TGF-beta antibodies in the treatment of renal injury.
    Gagliardini E; Benigni A
    Cytokine Growth Factor Rev; 2006; 17(1-2):89-96. PubMed ID: 16257566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Link between angiotensin II and TGF-beta in the kidney.
    Wolf G
    Miner Electrolyte Metab; 1998; 24(2-3):174-80. PubMed ID: 9525702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
    Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
    Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does TGF-β mediate tubulointerstitial fibrosis?
    Gewin L; Zent R
    Semin Nephrol; 2012 May; 32(3):228-35. PubMed ID: 22835453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
    López-Hernández FJ; López-Novoa JM
    Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubulointerstitial fibrosis. New thoughts on its development and progression.
    O'Donnell MP
    Postgrad Med; 2000 Jul; 108(1):159-62, 165, 171-2. PubMed ID: 10914125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta signal transduction and progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2002 Dec; 227(11):943-56. PubMed ID: 12486204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β and the progression of renal disease.
    Loeffler I; Wolf G
    Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i37-i45. PubMed ID: 24030832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway.
    Wolf G
    Kidney Int; 2006 Dec; 70(11):1914-9. PubMed ID: 16985515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transforming growth factor-beta: a new approach to the pathogenesis of glomerulonephritis and glomerulosclerosis].
    Witowski J; Knapowski J
    Przegl Lek; 1995; 52(9):467-73. PubMed ID: 8834649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of transforming growth factor-beta in kidney diseases.
    Sharma K; Ziyadeh FN
    Am J Physiol; 1994 Jun; 266(6 Pt 2):F829-42. PubMed ID: 8023963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β/Smad and Renal Fibrosis.
    Ma TT; Meng XM
    Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [TGF-beta: usage in nephrology].
    Quirin N; Feige JJ; Zaoui P
    Nephrologie; 1996; 17(4):227-35. PubMed ID: 8768454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
    Phanish MK; Wahab NA; Hendry BM; Dockrell ME
    Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?
    Ketteler M; Noble NA; Border WA
    Annu Rev Physiol; 1995; 57():279-95. PubMed ID: 7778869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TGF-β Signaling in Kidney Fibrosis.
    Isaka Y
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureic clearance granule, alleviates renal dysfunction and tubulointerstitial fibrosis by promoting extracellular matrix degradation in renal failure rats, compared with enalapril.
    Huang YR; Wei QX; Wan YG; Sun W; Mao ZM; Chen HL; Meng XJ; Shi XM; Tu Y; Zhu Q
    J Ethnopharmacol; 2014 Sep; 155(3):1541-52. PubMed ID: 25087615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.